HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by RUIZ, J. Articles by VILA, J. Search for Related Content PubMed PubMed Citation Articles by RUIZ, J. Articles by VILA, J. Agricola Articles by RUIZ, J. Articles by VILA, J.

Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium

Department of Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Villarroel 170, 08036 Barcelona

*Department of Microbiology, School of Sciences, University of Málaga, 29071 Málaga, Spain

Corresponding author: Dr J. Vila.

Received August 14, 1996
Accepted December 11, 1996

Over a period of 2.5 years, 42 cases of gastro-enteritis caused by nalidixic acid-resistant Salmonella serotype Typhimurium occurred in Malaga. The epidemiological relationship among the strains involved was investigated by analysis of plasmid profile and of chromosomal DNA by pulsed-field gel electrophoresis (PFGE). Despite having different plasmid profiles, all 42 nalidixic-acid resistant Typhimurium isolates had evolved from one clone as shown by analysis of chromosomal DNA by PFGE. The mechanism of quinolone resistance in these Typhimurium isolates was also investigated. Analysis of outer-membrane proteins and lipopolysaccharide from quinolone-susceptible and -resistant clinical isolates tested showed no differences. All nalidixic acid-resistant isolates had MICs for ciprofloxacin of 0.25 mg/L and for nalidixic acid of 1024 mg/L. Polymerase chain reaction fragments of 285 bp, containing the quinolone resistance-determining region of the gyrA gene, and of 237 bp, containing the region of parC homologous to the quinolone resistance-determining region of the gyrA gene, were sequenced. All resistant isolates presented a change at Ser-83 to Phe in the GyrA protein, but no changes were observed in the ParC protein. These findings indicated that this mutation in gyrA plays a major role in the acquisition of nalidixic-acid resistance in clinical isolates of Typhimurium.

This article has been cited by other articles:

				A. T. T. Vo, E. van Duijkeren, A. C. Fluit, and W. Gaastra A novel Salmonella genomic island 1 and rare integron types in Salmonella Typhimurium isolates from horses in The Netherlands J. Antimicrob. Chemother., April 1, 2007; 59(4): 594 - 599. [Abstract] [Full Text] [PDF]

				A. Murray, J. E. Coia, H. Mather, and D. J. Brown Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003 J. Antimicrob. Chemother., July 1, 2005; 56(1): 110 - 114. [Abstract] [Full Text] [PDF]

				R. Cabrera, J. Ruiz, F. Marco, I. Oliveira, M. Arroyo, A. Aladuena, M. A. Usera, M. T. Jimenez De Anta, J. Gascon, and J. Vila Mechanism of Resistance to Several Antimicrobial Agents in Salmonella Clinical Isolates Causing Traveler's Diarrhea Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3934 - 3939. [Abstract] [Full Text] [PDF]

				J. Ruiz Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection J. Antimicrob. Chemother., May 1, 2003; 51(5): 1109 - 1117. [Abstract] [Full Text] [PDF]

				M. P. Reche, J. E. Garcia de los Rios, P. A. Jimenez, A. M. Rojas, and R. Rotger gyrA Mutations Associated with Nalidixic Acid-Resistant Salmonellae from Wild Birds Antimicrob. Agents Chemother., September 1, 2002; 46(9): 3108 - 3109. [Full Text] [PDF]

				S. Valdezate, A. Vindel, A. Echeita, F. Baquero, and R. Canto Topoisomerase II and IV Quinolone Resistance-Determining Regions in Stenotrophomonas maltophilia Clinical Isolates with Different Levels of Quinolone Susceptibility Antimicrob. Agents Chemother., March 1, 2002; 46(3): 665 - 671. [Abstract] [Full Text] [PDF]

				M. M. Navia, J. Ruiz, A. Ribera, M. T. J. de Anta, and J. Vila Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii J. Antimicrob. Chemother., December 1, 1999; 44(6): 743 - 748. [Abstract] [Full Text] [PDF]

				K. Molbak, D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gerner-Smidt, A. M. Petersen, and H. C. Wegener An Outbreak of Multidrug-Resistant, Quinolone-Resistant Salmonella enterica Serotype Typhimurium DT104 N. Engl. J. Med., November 4, 1999; 341(19): 1420 - 1425. [Abstract] [Full Text] [PDF]

				E. Giraud, A. Brisabois, J.-L. Martel, and E. Chaslus-Dancla Comparative Studies of Mutations in Animal Isolates and Experimental In Vitro- and In Vivo-Selected Mutants of Salmonella spp. Suggest a Counterselection of Highly Fluoroquinolone-Resistant Strains in the Field Antimicrob. Agents Chemother., September 1, 1999; 43(9): 2131 - 2137. [Abstract] [Full Text]

				J. Ruiz, L. Capitano, L. Nunez, D. Castro, J. M. Sierra, M. Hatha, J. J. Borrego, and J. Vila Mechanisms of resistance to ampicillin, chloramphenicol and quinolones in multiresistant Salmonella typhimurium strains isolated from fish J. Antimicrob. Chemother., May 1, 1999; 43(5): 699 - 702. [Abstract] [Full Text] [PDF]